iSpecimen Inc. Class of Warrant or Right, Number of Securities Called by Warrants or Rights
iSpecimen Inc. (ISPC) had Class of Warrant or Right, Number of Securities Called by Warrants or Rights of 27.99 shares as of 2025-07-23, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights · last filed 2026-08-14
- 2025-07-23: Class of Warrant or Right, Number of Securities Called by Warrants or Rights 27.99 shares; Class of Warrant or Right, Number of Securities Called by Warrants or Rights as first filed 0.70 shares.
| Period end | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights as first filed |
|---|---|---|
| 2025-07-23 | 27.99 shares 10-Q · filed 2026-08-14 | 0.70 shares 10-Q · filed 2025-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |